Funding: Discover support for COVID-related research

The mission of the Office of Research is to promote research and improve health by providing high-quality service to investigators; fostering new research initiatives; and promoting translational discoveries into public benefit.

Funding makes your work possible. Search, locate and apply for funding opportunities that map to your research.

Contact your OSR Staff if you are interested in applying to any of these funding opportunities.

If you have funding opportunities that we should add, please send them to us.

  • PAR-25-292 The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional)

    Application Due Dates: please see NOFO

    Funder: NIH Multiple ICs – check NOFO for full list

    Topics: Clinical Presentation of Infection, ARDS, Cellular / Molecular Response, Inflammation, Long-term Impact of Infection, Pneumonia, Sensory, Clinical Trial, Co-Morbidities, COVID-19, ELSI (Ethical, Legal, and Social Implications), Environmental Health, Epidemiology, Clinical History, Clinical Outcome, Contact Tracing, Incidence, Risk Factors, Surveillance, Transmission, Aerosol, Health Disparities, Healthcare Implementation, Occupational Health, Research Site, Community-based, Social Determinants of Health, Target Population, Military Personnel, Healthcare Workers, Service Workers

  • PAR-25-271 NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)

    Application Due Dates: please see NOFO

    Funder: NIH National Center for Complementary and Integrative Health (NCCIH)

    Topics: Clinical Presentation of Infection, Long-term Impact of Infection, Clinical Trial, Co-Morbidities, COVID-19, Health Disparities, Healthcare Implementation, Product Development and Commercialization, Research Site, Community-based, International, Social Determinants of Health, Treatments, Treatment Efficacy, Treatment Reliability, Treatment Scalability, Drugs, Drug Development, Drug Repurposing, Drug Targets, Immunological Response Targets, Anti-viral Targets

  • PAR-25-270 NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)

    Application Due Dates: please see NOFO

    Funder: NIH National Center for Complementary and Integrative Health (NCCIH)

    Topics: Clinical Presentation of Infection, Long-term Impact of Infection, Clinical Trial, Co-Morbidities, COVID-19, Community Engagement, Health Disparities, Healthcare Implementation, Product Development and Commercialization, Research Site, Community-based, Social Determinants of Health, Treatments, Treatment Efficacy, Treatment Reliability, Treatment Scalability, Drugs, Drug Development, Drug Repurposing, Drug Targets, Immunological Response Targets, Anti-viral Targets

  • PAR-25-269 NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)

    Application Due Dates: please see NOFO

    Funder: NIH National Center for Complementary and Integrative Health (NCCIH)

    Topics: Clinical Presentation of Infection, Long-term Impact of Infection, Clinical Trial, Co-Morbidities, COVID-19, Community Engagement, Health Disparities, Healthcare Implementation, Product Development and Commercialization, Research Site, Community-based, Social Determinants of Health, Treatments, Treatment Efficacy, Treatment Reliability, Treatment Scalability, Drugs, Drug Development, Drug Repurposing, Drug Targets, Immunological Response Targets, Anti-viral Targets

  • PAR-25-268 Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)

    Application Due Dates: Please see NOFO

    Funder: NIH National Center for Complementary and Integrative Health (NCCIH)

    Topics: Clinical Presentation of Infection, ARDS, Cellular / Molecular Response, Pneumonia, Sensory, Clinical Trial, Co-Morbidities, Asthma, Cancer, Cardiovascular Disease, COVID-19, Community Engagement, Health Disparities, Healthcare Implementation, Mental Health, Psychology, Mobile Health, App, Telemedicine, Wearables, Occupational Health, Oral Science / Dentistry, Prevention, Research Site, Community-based, Social Determinants of Health, Treatments, Treatment Efficacy, Treatment Reliability, Treatment Scalability

  • PA-25-172 Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)

    Application Due Dates: please see NOFO

    Funder: NIH National Cancer Institute (NCI)

    Topics: Co-Morbidities, Cancer, COVID-19, Computational Analysis, Computational or Data Science Methods Development, Diagnostics, Environmental Health, Epidemiology, Clinical History, Clinical Outcome, Risk Factors, Health Disparities, Healthcare Implementation, Research Methods, Electronic Health Records (EHR), Research Tool Development, Social Determinants of Health

  • PAR-25-106 Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed)

    Application Due Dates: please see NOFO

    Funder: NIH National Cancer Institute (NCI)

    Topics: Applied Research, Vaccine Development, Vaccine Efficacy, Vaccine Reliability, Vaccine Scalability, Treatments, Treatment Efficacy, Treatment Reliability, Treatment Scalability, Drugs, Drug Development, Drug Repurposing, Drug Targets, Immunological Response Targets, Anti-viral Targets

  • PAR-25-201 Integrating Mental Health Care into Health Care Systems and Non-Health Settings in Low- and Middle-Income Countries (R01 Clinical Trial Optional)

    Application Due Dates: please see NOFO

    Funder: NIH Multiple ICs – check NOFO for full list

    Topics: Clinical Presentation of Infection, Long-term Impact of Infection, Clinical Trial, Co-Morbidities, COVID-19, Neurological Disorders, Substance Abuse, Community Engagement, Economic Impact, Education and Training, Digital Learning, ELSI (Ethical, Legal, and Social Implications), Environmental Health, Epidemiology, Health Disparities, Healthcare Implementation, Impact to Conduct of Research, Pandemic Context, Mental Health, Psychology, Research Site, Community-based, International

  • PAR-24-312 Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required)

    Application Due Dates: please see NOFO

    Funder: NIH National Center for Complementary and Integrative Health (NCCIH)

    Topics: Applied Research, Clinical Presentation of Infection, ARDS, Cellular / Molecular Response, Inflammation, Long-term Impact of Infection, Pneumonia, Sensory, Community Engagement, ELSI (Ethical, Legal, and Social Implications), Environmental Health, Health Disparities, Healthcare Implementation, Immunology, Host Factors, Host Response, Mental Health, Mobile Health, App, Wearables, Product Development and Commercialization, Virology, Viral Interactome, Viral Proteins, Virus Biology, Virus Evolution, Virus Factors, Social Determinants of Health, Treatments

  • PAR-25-116 Towards a Better Understanding of the Neurological Effects of Infection-Associated Chronic Illnesses (R01 - Clinical Trial Optional)

    Please NOFO for Application Due Dates.

    Funder: NIH Multiple ICs – check NOFO for full list

    Topics: Clinical Presentation of Infection, Cellular / Molecular Response, Inflammation, Long-term Impact of Infection, Clinical Trial, Co-Morbidities, COVID-19, Immune Disorders, HIV, Immunosuppression, Inflammation, Rheumatoid Disorders, Neurological Disorders, Community Engagement, Computational Analysis, ELSI (Ethical, Legal, and Social Implications), Epidemiology, Clinical History, Clinical Outcome, Health Disparities, Immunity, Immunology, Host Factors, Host Response, Mental Health, Research Model Development, Virology, Viral Interactome, Social Determinants of Health

  • PAR-25-115 Towards a Better Understanding of the Neurological Effects of Infection-Associated Chronic Illnesses (R21 - Clinical Trial Optional)

    Please see NOFO for Application Due Dates

    Funder: NIH Multiple ICs – check NOFO for full list

    Topics: Clinical Presentation of Infection, Cellular / Molecular Response, Inflammation, Long-term Impact of Infection, Clinical Trial, Co-Morbidities, COVID-19, Immune Disorders, HIV, Immunosuppression, Inflammation, Rheumatoid Disorders, Neurological Disorders, Community Engagement, Computational Analysis, ELSI (Ethical, Legal, and Social Implications), Epidemiology, Clinical History, Clinical Outcome, Health Disparities, Immunity, Immunology, Host Factors, Host Response, Mental Health, Research Model Development, Virology, Viral Interactome, Social Determinants of Health

  • PAR-24-272 Clinical and Translational Science Award (UM1 Clinical Trial Optional)

    Application Due Dates: please see NOFO

    Funder: NIH National Center for Advancing Translational Sciences (NCATS)

    Topics: Computational Analysis, Computational or Data Science Methods Development, Health Disparities, Healthcare Implementation, Research Methods, Research Tool Development, Social Determinants of Health

  • NOT-HL-24-018 Notice of Special Interest (NOSI): Stimulate Research on the Diagnosis, Treatment, and Mechanistic Understanding of Postural Orthostatic Tachycardia Syndrome (POTS)

    Please see the Notice for application due dates.

    Funder: NIH Multiple ICs – check NOSI for full list

    Topics: Clinical Presentation of Infection, Cellular / Molecular Response, Inflammation, Long-term Impact of Infection, Co-Morbidities, Cardiovascular Disease, COVID-19, Epidemiology, Clinical History, Clinical Outcome, Incidence, Risk Factors, Health Disparities, Organ, Heart, Cardiovascular, Prognostics, Virology, Viral Interactome, Viral Proteins, Virus Factors

  • NOT-AI-24-053 Notice of Special Interest (NOSI): Discovery and Development of Oral Small-molecule Direct-acting Antivirals Targeting Viruses of Pandemic Potential.

    Application due dates on or after October 5, 2024, and subsequent receipt dates through July 16, 2027

    Funder: NIH National Institute of Allergy and Infectious Diseases (NIAID)

    Topics: Applied Research, Biomarkers, Immunology, Host Factors, Host Response, Virology, Viral Interactome, Viral Proteins, Virus Biology, Virus Evolution, Virus Factors, Vaccine Development, Vaccine Efficacy, Vaccine Reliability, Vaccine Scalability, Vaccines, Treatments, Immunological Response Targets, Treatment Efficacy, Treatment Reliability, Treatment Scalability, Drugs, Drug Development, Drug Repurposing, Drug Targets, Immunological Response Targets, Anti-viral Targets

  • PAR-24-231 Community Level Interventions to Improve Minority Health and Reduce Health Disparities (R01 - Clinical Trial Optional)

    Please see NOFO for application due dates.

    Funder: NIH National Institute on Minority Health and Health Disparities (NIMHD)

    Topics: Co-Morbidities, COPD, COVID-19, Diabetes, Immune Disorders, HIV, Neurological Disorders, Substance Abuse, Community Engagement, Diagnostics, Economic Impact, ELSI (Ethical, Legal, and Social Implications), Health Disparities, Healthcare Implementation, Mental Health, Psychology, Mobile Health, App, Telemedicine, Wearables, Prevention, Prognostics, Screen, Vaccine Development, Vaccines, Vaccine Hesitancy, Social Determinants of Health, Treatments

  • PAR-24-116 NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)

    Application Due Dates: please see NOFO.

    Funder: NIH National Center for Complementary and Integrative Health (NCCIH)

    Topics: Applied Research, Clinical Presentation of Infection, Long-term Impact of Infection, Co-Morbidities, COVID-19, Community Engagement, Health Disparities, Healthcare Implementation, Mental Health, Psychology, Mobile Health, App, Telemedicine, Wearables, Treatments

  • PAR-24-115 NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)

    Application Due Dates: please see NOFO.

    Funder: NIH National Center for Complementary and Integrative Health (NCCIH)

    Topics: Applied Research, Clinical Presentation of Infection, Long-term Impact of Infection, Clinical Trial, Co-Morbidities, COVID-19, Community Engagement, Health Disparities, Healthcare Implementation, Mental Health, Psychology, Mobile Health, App, Telemedicine, Wearables, Treatments

  • PAR-24-124 NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)

    Application Due Dates: please see NOFO.

    Funder: NIH National Center for Complementary and Integrative Health (NCCIH)

    Topics: Applied Research, Clinical Presentation of Infection, Long-term Impact of Infection, Clinical Trial, Co-Morbidities, COVID-19, Neurological Disorders, Substance Abuse, Community Engagement, Health Disparities, Healthcare Implementation, Mental Health, Psychology, Mobile Health, App, Telemedicine, Wearables, Treatments

  • PAR-24-086 Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)

    Please see NOFO for application due dates

    Funder: NIH National Center for Complementary and Integrative Health (NCCIH)

    Topics: Clinical Presentation of Infection, ARDS, Cellular / Molecular Response, Inflammation, Long-term Impact of Infection, Pneumonia, Sensory, Clinical Trial, Co-Morbidities, COVID-19, Community Engagement, ELSI (Ethical, Legal, and Social Implications), Health Disparities, Healthcare Implementation, Mobile Health, App, Telemedicine, Wearables, Prevention, Social Determinants of Health, Treatments, Treatment Efficacy, Treatment Reliability, Treatment Scalability

  • NOT-DC-24-001 Notice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of Post-Acute Sequelae of SARS-CoV-2 Infection on Mission Specific Sensory and Communication Disorder

    Application Due Dates: on or after January 30, 2024 and subsequent receipt dates through January 29, 2027

    Funder: NIH National Institute on Deafness and Other Communication Disorders (NIDCD)

    Topics: Biomarkers, Clinical Presentation of Infection, ARDS, Cellular / Molecular Response, Inflammation, Long-term Impact of Infection, Pneumonia, Sensory, Clinical Trial, Co-Morbidities, COVID-19, Immune Disorders, Inflammation, Neurological Disorders, ELSI (Ethical, Legal, and Social Implications), Environmental Health, Epidemiology, Clinical History, Clinical Outcome, Contact Tracing, Incidence, Risk Factors, Health Disparities, Healthcare Implementation, Immunity, Immunology, Host Factors, Host Response, Mobile Health, App, Telemedicine, Wearables, Oral Science / Dentistry, Organ, Brain, Oral Cavity, Prognostics, Research Methods, Cell Culture, Electronic Health Records (EHR), Imaging, Immunofluorescence, Screen, Sequencing, Research Site, Community-based, Virology, Viral Interactome, Viral Proteins, Target Population, Deaf Persons

  • NOT-HL-23-110 Notice of Special Interest (NOSI): Data Informed, Place-Based Community-Engaged Research to Advance Health Equity

    Application Due Dates: please see relevant NOFO

    Funder: NIH Multiple ICs – check NOSI for full list

    Topics: Clinical Presentation of Infection, ARDS, Cellular / Molecular Response, Inflammation, Long-term Impact of Infection, Pneumonia, Sensory, Clinical Trial, Co-Morbidities, Asthma, Cancer, Cardiovascular Disease, Cirrhosis, COPD, COVID-19, Diabetes, Gastroesophageal Reflux Disease (GERD), Hidradentis Supporativa, Immune Disorders, HIV, Immunosuppression, Inflammation, Rheumatoid Disorders, Neurological Disorders, Substance Abuse, Community Engagement, Computational Analysis, Computational or Data Science Methods Development, Economic Impact, Education and Training, ELSI (Ethical, Legal, and Social Implications), Environmental Health, Epidemiology, Clinical History, Clinical Outcome, Contact Tracing, Incidence, Risk Factors, Surveillance, Transmission, Aerosol, Health Disparities, Healthcare Implementation, Impact to Conduct of Research, Pandemic Context, Mental Health, Research Methods, Electronic Health Records (EHR), Research Site, Community-based, Social Determinants of Health

  • PAR-24-077 Addressing Health and Health Care Disparities among Sexual and Gender Minority Populations (R01 - Clinical Trials Optional)

    Application Due Dates: please see NOFO

    Funder: NIH Multiple ICs – check NOFO for full list

    Topics: Co-Morbidities, COVID-19, Community Engagement, Computational Analysis, Diagnostics, Diagnostics Development, Diagnostic Efficacy, Diagnostic Reliability, Diagnostic Scalability, ELSI (Ethical, Legal, and Social Implications), Environmental Health, Epidemiology, Clinical History, Clinical Outcome, Contact Tracing, Incidence, Risk Factors, Surveillance, Transmission, Aerosol, Health Disparities, Healthcare Implementation, Immunity, Immunology, Host Factors, Host Response, Mental Health, Psychology, Mobile Health, App, Telemedicine, Wearables, Research Site, Community-based, Vaccine Development, Vaccine Efficacy, Vaccine Reliability, Vaccine Scalability, Vaccines, Vaccine Hesitancy, Social Determinants of Health, Treatments, Treatment Efficacy, Treatment Reliability, Treatment Scalability, Drugs, Antibody-based Treatment, Convalescent Serum, Drug Development, Drug Repurposing, Drug Targets

  • PA-24-093 Systems-Based Approaches to Improve Patient Safety by Improving Healthcare Worker Safety and Well-Being (R01 Clinical Trial Optional)

    Application Due Dates: Standard dates apply starting with February 5, 2024

    Funder: HHS Agency for Healthcare Research and Quality

    Topics: Epidemiology, Clinical History, Clinical Outcome, Contact Tracing, Incidence, Risk Factors, Surveillance, Transmission, Aerosol, Impact to Conduct of Research, Pandemic Context, Target Population, Healthcare Workers

  • NOT-MD-23-019 Notice of Special Interest (NOSI): Administrative Supplements to Support Addiction Science and Related Neuroscience Pilot Research Projects at NIMHD-Funded Research Centers in Minority Institutions (RCMI)

    Application Due Dates:  April 17, 2024, October 17, 2024, January 17, 2025, April 17, 2025, October 17, 2025, January 17, 2026 and April 17, 2026 

    Funder: NIH Multiple ICs – check NOFO for full list

    Topics: Clinical Presentation of Infection, Long-term Impact of Infection, Clinical Trial, Co-Morbidities, COVID-19, Substance Abuse, Community Engagement, Computational Analysis, Computational or Data Science Methods Development, Economic Impact, Education and Training, ELSI (Ethical, Legal, and Social Implications), Health Disparities, Healthcare Implementation, Impact to Conduct of Research, Pandemic Context, Mental Health, Mobile Health, App, Telemedicine, Wearables, Research Site, Community-based, Vaccines, Vaccine Hesitancy, Social Determinants of Health

  • PAR-23-303 Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in Latin America: Setting the Stage for Better Health Outcomes Across the Hemisphere (R01 - Clinical Trials Not Allowed)

    For Application Due Dates, please see the NOFO

    Funder: NIH Multiple ICs – check NOFO for full list

    Topics: Clinical Presentation of Infection, Long-term Impact of Infection, Co-Morbidities, COVID-19, Diabetes, Computational Analysis, Economic Impact, ELSI (Ethical, Legal, and Social Implications), Environmental Health, Epidemiology, Health Disparities, Healthcare Implementation, Social Determinants of Health

  • RFA-DA-25-011 Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders

    AIDS Application Due Date: August 14, 2025

    Funder: NIH: National Institute on Drug Abuse (NIDA)

    Topics: Clinical Presentation of Infection, ARDS, Cellular / Molecular Response, Inflammation, Long-term Impact of Infection, Pneumonia, Sensory, Clinical Trial, Co-Morbidities, COVID-19, Immune Disorders, HIV, Immunosuppression, Inflammation, Rheumatoid Disorders, Neurological Disorders, Substance Abuse, Community Engagement, Health Disparities, Immunity, Immunology, Host Factors, Host Response, Mental Health

  • NOT-AA-23-011 Notice of Special Interest: Secondary Analyses of Existing Alcohol Research Data

    Application due dates on or after October 05, 2023, and subsequent receipt dates through September 06, 2026

    Funder: NIH National Institute on Alcohol Abuse and Alcoholism (NIAAA)

    Topics: COVID-19, Substance Abuse

  • NOT-CA-23-071 Notice of Special Interest (NOSI): Administrative Supplements for Enhancing Recruitment and Retention of Diverse Populations to Cancer Screening, Cancer Prevention and Symptom Management Clinical Trials

    Application Due Dates: February 28, 2024 and June 30, 2025

    Funder: NIH National Cancer Institute (NCI)

    Topics: Community Engagement, ELSI (Ethical, Legal, and Social Implications), Health Disparities, Healthcare Implementation, Impact to Conduct of Research, Pandemic Context

  • NOT-HL-23-083 Notice of Special Interest (NOSI): Assessing Real-World Effectiveness and Implementation of Telehealth-Guided Provider-to-Provider Communication among Rural Communities

    Application due dates on or after October 5, 2023 and subsequent receipt dates through October 9, 2026

    Funder: NIH Multiple ICs – check FOA for full list

    Topics: Co-Morbidities, COVID-19, Community Engagement, Computational Analysis, Computational or Data Science Methods Development, Economic Impact, ELSI (Ethical, Legal, and Social Implications), Health Disparities, Healthcare Implementation, Impact to Conduct of Research, Pandemic Context, Mobile Health, App, Telemedicine, Research Methods, Electronic Health Records (EHR), Research Site, Community-based, Social Determinants of Health

  • NOT-HS-23-013 Special Emphasis Notice: AHRQ Announces Interest in Health Services Research to Advance Health and Healthcare Equity.

    See RFA for deadline.

    Funder: Agency for Healthcare Research and Quality (AHRQ)

    Topics: Clinical Presentation of Infection, Long-term Impact of Infection, Co-Morbidities, COVID-19, Education and Training, ELSI (Ethical, Legal, and Social Implications), Health Disparities, Healthcare Implementation

  • PAR-23-169 Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed)

    Application Due Dates: August 2, 2023, August 2, 2024, August 1, 2025

    Funder: NIH: National Institute of Allergy and Infectious Diseases (NIAID)

    Topics: Co-Morbidities, COVID-19, Immune Disorders, HIV, Immunosuppression, Inflammation, Computational or Data Science Methods Development, Health Disparities, Healthcare Implementation, Immunity, Immunology, Host Factors, Host Response, Impact to Conduct of Research, Pandemic Context, Research Facilities Development, Vaccine Development, Vaccine Efficacy, Vaccine Reliability, Vaccine Scalability, Vaccines, Research Tool Development

  • NOT-HL-23-080 Notice of Special Interest (NOSI): Enhancing Research on Deciphering Mechanisms of COVID-19-Associated Coagulopathy

    Application due dates on or after June 5, 2023 and subsequent receipt dates through July 5, 2025.

    Funder: NIH: National Heart, Lung, and Blood Institute (NHLBI)

    Topics: Biomarkers, Clinical Presentation of Infection, Cellular / Molecular Response, Inflammation, Long-term Impact of Infection, Co-Morbidities, Cardiovascular Disease, COVID-19, Diabetes, Immune Disorders, HIV, Immunosuppression, Inflammation, Rheumatoid Disorders, Community Engagement, Computational or Data Science Methods Development, Epidemiology, Clinical History, Clinical Outcome, Risk Factors, Health Disparities, Healthcare Implementation, Immunity, Immunology, Host Factors, Host Response, Organ, Brain, Endocrine, GI, Heart, Cardiovascular, Kidney, Liver, Lung, Prognostics, Research Methods, Cell Culture, Electronic Health Records (EHR), Imaging, Immunofluorescence, Screen, Sequencing, Research Model Development, Research Models, Mouse Models, Non-Human Animal Models, Organoid Models, Virology, Viral Interactome, Viral Proteins, Virus Factors, Research Tool Development

  • NOT-AA-23-003 Notice of Special Interest: Advancing mHealth Interventions for Understanding and Preventing Alcohol-Related Domestic Violence

    Application due dates on or after June 5, 2023 and subsequent receipt dates through September 7, 2026

     

    Funder: NIH: National Institute on Alcohol Abuse and Alcoholism (NIAAA)

    Topics: Co-Morbidities, COVID-19, Community Engagement, Economic Impact, Education and Training, Digital Learning, ELSI (Ethical, Legal, and Social Implications), Environmental Health, Epidemiology, Clinical History, Clinical Outcome, Health Disparities, Healthcare Implementation, Mental Health, App, Telemedicine, Wearables, Research Site, Community-based, Social Determinants of Health

  • NOT-DE-23-004 Notice of Special Interest (NOSI): NIDCR Support for Research on the Physiological Involvement of Oral Cavity in Coronavirus Disease 2019 (COVID-19)

    Application due dates on or after Oct 5, 2023, and subsequent receipt dates through May 7, 2026

    Funder: NIH: National Institute of Dental and Craniofacial Research (NIDCR)

    Topics: Antibody, Biomarkers, Clinical Presentation of Infection, ARDS, Cellular / Molecular Response, Inflammation, Long-term Impact of Infection, Pneumonia, Sensory, Clinical Trial, Co-Morbidities, COPD, COVID-19, Gastroesophageal Reflux Disease (GERD), Hidradentis Supporativa, Immune Disorders, HIV, Immunosuppression, Inflammation, Neurological Disorders, Substance Abuse, Computational or Data Science Methods Development, Diagnostics, Economic Impact, Environmental Health, Epidemiology, Clinical History, Clinical Outcome, Risk Factors, Transmission, Aerosol, Health Disparities, Healthcare Implementation, Immunity, Immunology, Host Factors, Host Response, Oral Science / Dentistry, Organ, Oral Cavity, Prevention, Product Development and Commercialization, Prognostics, Research Methods, Cell Culture, Electronic Health Records (EHR), Imaging, Immunofluorescence, Screen, Sequencing, Research Model Development, Research Models, Mouse Models, Non-Human Animal Models, Virology, Viral Interactome, Viral Proteins, Virus Biology, Virus Evolution, Virus Factors, Vaccine Development, Vaccine Efficacy, Vaccine Reliability, Vaccine Scalability, Research Tool Development, Treatments, Treatment Efficacy, Treatment Reliability, Treatment Scalability, Drugs, Antibody-based Treatment, Drug Development, Drug Repurposing, Drug Targets, Immunological Response Targets, Anti-viral Targets

  • NOT-MD-23-008 Notice of Special Interest (NOSI): Research to Address Vaccine Uptake and Implementation among Populations Experiencing Health Disparities

    Multiple due dates, please see FOA for details.

    Funder: NIH Multiple ICs – check FOA for full list

    Topics: Clinical Trial, Community Engagement, Economic Impact, Education and Training, Digital Learning, ELSI (Ethical, Legal, and Social Implications), Health Disparities, Healthcare Implementation, Mobile Health, App, Telemedicine, Wearables, Research Site, Community-based, Vaccine Development, Vaccines, Vaccine Hesitancy, Social Determinants of Health, Target Population

  • NOT-AI-23-012 Notice of Special Interest (NOSI): Complement in Fundamental Immunology

    Application due dates on or after February 5, 2023 and subsequent receipt dates through January 7, 2026.

    Funder: NIH National Institute of Allergy and Infectious Diseases (NIAID)

    Topics: Clinical Presentation of Infection, ARDS, Cellular / Molecular Response, Inflammation, Long-term Impact of Infection, Pneumonia, Sensory, Clinical Trial, Co-Morbidities, COVID-19, Immune Disorders, Inflammation, Community Engagement, Computational Analysis, Health Disparities, Immunity, Immunology

  • NOT-DA-24-002 Notice of Special Interest (NOSI): Chemsex and HIV: prevalence, medical/psychosocial consequences, and treatment

    Application due dates on or after January 5, 2023 and subsequent receipt dates through January 7, 2026

    Funder: NIH National Institute on Drug Abuse

    Topics: Co-Morbidities, COVID-19, Immune Disorders, HIV, Immunosuppression, Substance Abuse, Epidemiology, Clinical History, Clinical Outcome, Incidence, Risk Factors, Health Disparities, Target Population, Treatments

  • NOT-HS-23-003 AHRQ Announces Interest in Healthcare Associated Infections and Combating Antibiotic Resistant Bacteria Research

    See applicable FOA for application due dates.

    Funder: HHS Agency for Healthcare Research and Quality

    Topics: Clinical Trial, Co-Morbidities, COVID-19, Community Engagement, Epidemiology, Clinical History, Health Disparities, Healthcare Implementation, Immunity, Immunology, Host Factors, Host Response, Impact to Conduct of Research, Pandemic Context, Virology, Viral Interactome, Viral Proteins, Virus Biology, Virus Evolution, Virus Factors, Vaccine Development, Vaccine Efficacy, Vaccine Reliability, Vaccine Scalability, Social Determinants of Health, Target Population, Treatments, Treatment Efficacy, Treatment Reliability, Treatment Scalability

  • NOT-DA-22-084 Notice of Special Interest (NOSI): Research on the Impact of Policy Changes and Emerging and Evolving Public Health Crises on NIDA Populations of Interest

    Application due dates on or after February 5, 2023 and subsequent receipt dates through January 8, 2026

     

    Funder: NIH National Institute on Drug Abuse

    Topics: Co-Morbidities, COVID-19, Substance Abuse, Community Engagement, Economic Impact, Education and Training, Digital Learning, ELSI (Ethical, Legal, and Social Implications), Epidemiology, Health Disparities, Healthcare Implementation, Vaccines, Vaccine Hesitancy, Social Determinants of Health, Target Population, Children, Pregnant Women, Teens

  • NOT-AI-22-064 Notice of Special Interest (NOSI): Halting Tuberculosis (TB) Transmission

    Application receipt dates on or after February 5, 2023 and subsequent receipt dates through January 7, 2026

    Funder: NIH National Institute of Allergy and Infectious Diseases (NIAID)

    Topics: Clinical Trial, Co-Morbidities, COVID-19, Community Engagement, Epidemiology, Incidence, Risk Factors, Transmission, Aerosol, Health Disparities, Healthcare Implementation, Immunity, Immunology, Host Factors, Host Response, Organ, Lung, Prevention, PPE, Social Distancing, Research Site, Benioff Children’s Hospital Oakland (BCHO), International, Vaccines, Vaccine Hesitancy, Social Determinants of Health, Target Population

  • NOT-OD-22-166 Notice of Special Interest (NOSI): Research on the Health of Bisexual and Bisexual+ People

    Please see the Notice for the list of application due dates.

    Funder: NIH Multiple ICs – check FOA for full list

    Topics: Clinical Presentation of Infection, ARDS, Cellular / Molecular Response, Inflammation, Long-term Impact of Infection, Pneumonia, Sensory, Clinical Trial, Co-Morbidities, COVID-19, Community Engagement, Economic Impact, Education and Training, Digital Learning, ELSI (Ethical, Legal, and Social Implications), Environmental Health, Epidemiology, Clinical History, Clinical Outcome, Contact Tracing, Incidence, Risk Factors, Surveillance, Transmission, Aerosol, Health Disparities, Healthcare Implementation, Impact to Conduct of Research, Pandemic Context, Social Determinants of Health, Target Population

  • NOT-DA-23-008 Notice of Special Interest (NOSI) HEAL Initiative: Workforce Interventions to Improve Addiction Care Quality and Patient Outcomes

    Application due dates on or after October 5, 2022 and subsequent receipt dates through September 8, 2025.

    Funder: NIH Multiple ICs – check FOA for full list

    Topics: Clinical Trial, Co-Morbidities, COVID-19, Neurological Disorders, Substance Abuse, Community Engagement, Education and Training, Digital Learning, ELSI (Ethical, Legal, and Social Implications), Health Disparities, Healthcare Implementation, Impact to Conduct of Research, Pandemic Context, Mental Health, Psychology, Mobile Health, App, Telemedicine, Wearables, Occupational Health

  • NOT-OD-22-167 Notice of Special Interest (NOSI): Research on Addressing Violence to Improve Health Outcomes

    Application due dates on or after September 7, 2022 and subsequent receipt dates through October 5, 2025.

    Funder: NIH Multiple ICs – check FOA for full list

    Topics: Co-Morbidities, COVID-19, ELSI (Ethical, Legal, and Social Implications), Health Disparities, Healthcare Implementation, Impact to Conduct of Research, Pandemic Context, Mental Health, Psychology, Social Determinants of Health

  • NOT-HL-22-030 Notice of Special Interest (NOSI): Studies of Cellular/Molecular Pathobiological Mechanisms of Lung Diseases Using Human 3-Dimensional Cellular Systems (R01)

    Application due dates on or after September 25, 2022 and subsequent receipt dates through September 7, 2025.

    Funder: NIH National Heart Lung and Blood Institute (NHLBI)

    Topics: Biospecimen Science, Clinical Presentation of Infection, ARDS, Cellular / Molecular Response, Inflammation, Long-term Impact of Infection, Pneumonia, Sensory, Immunity, Immunology, Host Factors, Host Response, Organ, Lung, Prognostics, Research Methods, Research Model Development, Research Models, Organoid Models, Virology, Viral Interactome, Viral Proteins, Virus Biology, Virus Evolution, Virus Factors

  • PAR-22-145 Leveraging Health Information Technology (Health IT) to Address and Reduce Health Care Disparities (R01 Clinical Trial Optional)

    Application Due Dates: please see FOA

    Funder: NIH Multiple ICs – check FOA for full list

    Topics: Clinical Presentation of Infection, Clinical Trial, Co-Morbidities, Community Engagement, Computational Analysis, Computational or Data Science Methods Development, Diagnostics, Economic Impact, Education and Training, Digital Learning, ELSI (Ethical, Legal, and Social Implications), Environmental Health, Epidemiology, Clinical Outcome, Contact Tracing, Incidence, Risk Factors, Surveillance, Transmission, Aerosol, Health Disparities, Healthcare Implementation, Impact to Conduct of Research, Pandemic Context, Mobile Health, App, Telemedicine, Wearables, Occupational Health, Oral Science / Dentistry, Prevention, Prognostics, Research Methods, Electronic Health Records (EHR), Research Site, Community-based, Vaccines, Vaccine Hesitancy, Social Determinants of Health, Target Population, Children, Deaf Persons, Elderly, Homeless Persons, Pregnant Women, Prisoners, Service Workers, Teens, Visually Impaired, Treatments

  • NOT-HL-23-003 Notice of Special Interest (NOSI): Enhancing Research on Deciphering Mechanisms of COVID-19-Associated Coagulopathy

    Application Due Dates: on or after June 5, 2022 and subsequent receipt dates through July 5, 2025.

    Funder: NIH National Heart Lung and Blood Institute (NHLBI)

    Topics: Organ, Heart, Cardiovascular, Immunology, Host Response, Host Factors, Research Models, Non-Human Animal Models, Organoid Models, Mouse Models, Research Model Development, Research Methods, Sequencing, Screen, Immunofluorescence, Imaging, Cell Culture, Prognostics, Co-Morbidities, Immune Disorders, Inflammation, Immunosuppression, HIV, Rheumatoid Disorders, Diabetes, COVID-19, Cardiovascular Disease, Clinical Trial, Community Engagement, Social Determinants of Health, Virology, Viral Interactome, Viral Proteins, Virus Biology, Virus Factors

  • NOT-HL-22-004 Notice of Special Interest (NOSI) Pediatric COVID-19 and Respiratory Viral Co-infection

    Application due dates on or after February 5, 2022 and subsequent receipt dates through September 8, 2025.

    Funder: NIH Multiple ICs – check FOA for full list

    Topics: Virology, Viral Interactome, Viral Proteins, Virus Biology, Virus Evolution, Virus Factors